Samsung Biologics Labor and Management to Resume Talks on Nov. 17... Two Weeks After Postponement
Participants increase from 400 to 500
Samsung Biologics' labor and management, which have been in conflict over wages and benefits, will resume negotiations on November 17.
According to industry sources on November 13, Samsung Biologics' labor and management agreed to resume negotiations on November 17. The company first proposed resuming talks on that date, and the union accepted.
The Samsung Biologics union has been staging its second partial strike since November 6. The number of participants has grown from an initial 400 to 500. The number of departments participating has also expanded every three days, and seven departments, including the Test Method Technology Transfer Group and the Non-Routine Testing Group, joined the strike starting November 12. The union has said it plans to continue the second strike for about three weeks, through November 27.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The union began its second partial strike after negotiations scheduled for November 3 were postponed when the company notified it of a delay. In May, the union staged the company's first full-scale strike since its founding. The company estimates that the production of some batches was halted at the time, resulting in losses of approximately 150 billion won.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
